These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 9088579

  • 1. Theophylline has no advantages over caffeine as a putative model drug for assessing CYPIA2 activity in humans.
    Rasmussen BB, Brøsen K.
    Br J Clin Pharmacol; 1997 Mar; 43(3):253-8. PubMed ID: 9088579
    [Abstract] [Full Text] [Related]

  • 2. Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans.
    Rasmussen BB, Brøsen K.
    Ther Drug Monit; 1996 Jun; 18(3):254-62. PubMed ID: 8738764
    [Abstract] [Full Text] [Related]

  • 3. Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities.
    Fuchs P, Haefeli WE, Ledermann HR, Wenk M.
    Eur J Clin Pharmacol; 1999 Jan; 54(11):869-76. PubMed ID: 10027663
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations.
    Fuhr U, Rost KL, Engelhardt R, Sachs M, Liermann D, Belloc C, Beaune P, Janezic S, Grant D, Meyer UA, Staib AH.
    Pharmacogenetics; 1996 Apr; 6(2):159-76. PubMed ID: 9156694
    [Abstract] [Full Text] [Related]

  • 5. Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test.
    Rost KL, Roots I.
    Clin Pharmacol Ther; 1994 Apr; 55(4):402-11. PubMed ID: 8162667
    [Abstract] [Full Text] [Related]

  • 6. Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.
    McQuilkin SH, Nierenberg DW, Bresnick E.
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):139-46. PubMed ID: 7742721
    [Abstract] [Full Text] [Related]

  • 7. Determination of theophylline and its metabolites in human urine and plasma by high-performance liquid chromatography.
    Rasmussen BB, Brøsen K.
    J Chromatogr B Biomed Appl; 1996 Feb 09; 676(1):169-74. PubMed ID: 8852059
    [Abstract] [Full Text] [Related]

  • 8. In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.
    Begas E, Kouvaras E, Tsakalof A, Papakosta S, Asprodini EK.
    Biomed Chromatogr; 2007 Feb 09; 21(2):190-200. PubMed ID: 17221922
    [Abstract] [Full Text] [Related]

  • 9. Griseofulvin and fluvoxamine interactions with the metabolism of theophylline.
    Rasmussen BB, Jeppesen U, Gaist D, Brøsen K.
    Ther Drug Monit; 1997 Feb 09; 19(1):56-62. PubMed ID: 9029748
    [Abstract] [Full Text] [Related]

  • 10. Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.
    Fuhr U, Rost KL.
    Pharmacogenetics; 1994 Jun 09; 4(3):109-16. PubMed ID: 7920690
    [Abstract] [Full Text] [Related]

  • 11. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
    Daniel WA, Syrek M, Ryłko Z, Kot M.
    Pol J Pharmacol; 2001 Jun 09; 53(6):615-21. PubMed ID: 11985335
    [Abstract] [Full Text] [Related]

  • 12. Lack of correlation between fluvoxamine clearance and CYP1A2 activity as measured by systemic caffeine clearance.
    Spigset O, Hägg S, Söderström E, Dahlqvist R.
    Eur J Clin Pharmacol; 1999 Feb 09; 54(12):943-6. PubMed ID: 10192755
    [Abstract] [Full Text] [Related]

  • 13. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
    Kinzig-Schippers M, Fuhr U, Zaigler M, Dammeyer J, Rüsing G, Labedzki A, Bulitta J, Sörgel F.
    Clin Pharmacol Ther; 1999 Mar 09; 65(3):262-74. PubMed ID: 10096258
    [Abstract] [Full Text] [Related]

  • 14. Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2.
    Labedzki A, Buters J, Jabrane W, Fuhr U.
    Biochem Pharmacol; 2002 Jun 15; 63(12):2159-67. PubMed ID: 12110375
    [Abstract] [Full Text] [Related]

  • 15. Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults.
    Cazeneuve C, Pons G, Rey E, Treluyer JM, Cresteil T, Thiroux G, D'Athis P, Olive G.
    Br J Clin Pharmacol; 1994 May 15; 37(5):405-12. PubMed ID: 8054245
    [Abstract] [Full Text] [Related]

  • 16. [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities].
    Lu JF, Yi T, Cao XM, Zhuo HT, Ling SS.
    Yao Xue Xue Bao; 1997 Nov 15; 32(11):813-8. PubMed ID: 11596199
    [Abstract] [Full Text] [Related]

  • 17. Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.
    Sohn JA, Kim HS, Oh J, Cho JY, Yu KS, Lee J, Shin SH, Lee JA, Choi CW, Kim EK, Kim BI, Park EA.
    Br J Clin Pharmacol; 2017 Jun 15; 83(6):1279-1286. PubMed ID: 27995649
    [Abstract] [Full Text] [Related]

  • 18. Effect of age on patterns of theophylline metabolism.
    Grygiel JJ, Birkett DJ.
    Clin Pharmacol Ther; 1980 Oct 15; 28(4):456-62. PubMed ID: 7408405
    [Abstract] [Full Text] [Related]

  • 19. A fluvoxamine-caffeine interaction study.
    Jeppesen U, Loft S, Poulsen HE, Brśen K.
    Pharmacogenetics; 1996 Jun 15; 6(3):213-22. PubMed ID: 8807660
    [Abstract] [Full Text] [Related]

  • 20. Paraxanthine/Caffeine Concentration Ratios in Hair: An Alternative for Plasma-Based Phenotyping of Cytochrome P450 1A2?
    De Kesel PM, Lambert WE, Stove CP.
    Clin Pharmacokinet; 2015 Jul 15; 54(7):771-81. PubMed ID: 25603821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.